Discovery of a dimmer switch to control drug action holds promise for the development of next-generation treatments for schizophrenia and other central nervous system disorders. [ + ]

Three young researchers from Melbourne are the winners of the 2014 L'Oréal Australia & New Zealand for Women in Science Fellowships. [ + ]

If you want to find out what science industry customers really want, you need to attend Australian Science Industry Exchange on 20 August. [ + ]

The SIA's one-day conference, Australian Science Industry Exchange, will give science industry vendors a unique insight into the needs of Australian science industry consumers. [ + ]

Biotech industry associations join forces to express concerns about changes to US non-statutory patent law. [ + ]

GI Dynamics (ASX:GID) has signed on the first obese patients for a utility trial of EndoBarrier in France and reported year-on-year revenue growth but a wider net loss for Q1. [ + ]

Researchers from La Trobe University have set up a crowdfunding page to enable research into the exposure of frogs to pesticides. [ + ]

Therapeutic Innovation Australia (TIA) has launched the Australian Therapeutic Pipeline - a collaborative initiative to better enable Australian researchers to translate their health discoveries into clinical application. [ + ]

Mesoblast and the US National Institutes of Health will team up for a 120-patient trial of the company's MPCs in end-stage heart failure. [ + ]

Finalists across the spectrum of life sciences, from research in agriculture and infectious diseases to science journalism and photography, have been announced for the 2014 Australian Museum Eureka Prizes. [ + ]

The National Health and Medical Research Council (NHMRC) today announced the first steps in its delivery of the Australian Government's $200 million 'Boosting Dementia Research' budget measure. [ + ]

The Scientific Committee on Antarctic Research (SCAR) has convened 75 scientists and policymakers from 22 countries to agree on the priorities for Antarctic research for the next 20 years and beyond. [ + ]

The future looks bright for the use of graphene in the mass production of biocompatible sensor devices with the development of a new microfabrication process. [ + ]

AusBiotech's substantive submission to the Senate Standing Committee on Economics' Australian Innovation System inquiry has called for tax reform, support for commercialisation, incentives for commercial thinking and clinical trial reform. [ + ]

Immuron's (ASX:IMC) distribution partner Paladin Labs has launched OTC travellers' diarrhoea treatment Travelan in Canada. [ + ]